Compare TYRA & UNFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TYRA | UNFI |
|---|---|---|
| Founded | 2018 | 1976 |
| Country | United States | United States |
| Employees | N/A | 25600 |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.4B |
| IPO Year | 2021 | 1996 |
| Metric | TYRA | UNFI |
|---|---|---|
| Price | $35.08 | $47.78 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 7 |
| Target Price | ★ $47.50 | $44.71 |
| AVG Volume (30 Days) | ★ 1.1M | 547.6K |
| Earning Date | 05-06-2026 | 06-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $0.47 |
| Revenue Next Year | N/A | $2.18 |
| P/E Ratio | ★ N/A | $193.12 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.75 | $21.27 |
| 52 Week High | $40.65 | $49.84 |
| Indicator | TYRA | UNFI |
|---|---|---|
| Relative Strength Index (RSI) | 45.54 | 60.86 |
| Support Level | $33.81 | $34.26 |
| Resistance Level | $39.90 | $49.84 |
| Average True Range (ATR) | 1.97 | 1.47 |
| MACD | -0.11 | -0.17 |
| Stochastic Oscillator | 29.08 | 52.89 |
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
United Natural Foods Inc is a wholesale distributor of natural, organic and specialty foods and nonfood products across North America. The company's products consist of national, regional and private label brands grouped into grocery and general merchandise, produce, perishables and frozen foods, nutritional supplements and sports nutrition, bulk and foodservice products, and personal care items. United Natural Foods serves various retail formats including conventional supermarket chains, natural product superstores, independent retail operators and foodservice channels such as e-commerce platforms. The company's operations are comprised of principal divisions: the wholesale division; the retail division; and other.